U.S. Markets open in 4 hrs, 30 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 6.05 11:38 AM EST | |
|---|---|---|
| Day High | 6.29 09:42 AM EST |
|
| Range | 0.24 |
| Volume | 2.93 M | |
|---|---|---|
| 30-Day Avg Vol | 3.73 M |
|
| Difference | -21.30% |
| Market Cap | 645.47 M | |
|---|---|---|
| Mkt Cap Chg | 33.26 M |
| Shares Out | 103.94 M | |
|---|---|---|
| % Shrs Traded | 2.83% | |
| 1yr EPS Est | -0.495 |
| 52-Wk Low | 4.68 | |
|---|---|---|
| 52-Wk High | 9.30 |
|
| Range | 4.62 |
| Prev Close | 5.89 11/5/09 | |
|---|---|---|
| Today's Open | 6.18 | |
| Change | 4.92% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.86 M |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -51.73 M | |
| Earnings (MRQ) | -18.67 M | |
| Next Earn Est | -0.208 | |
| Next Earnings | 03/01/2010 |
|
| EPS (TTM) | -0.76 | |
| 1yr EPS Growth | 35.71% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -12.00 | |
| PEG Ratio | — | |
| Return on Equity | -78.61 | |
| Beta | 0.45 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Drug developer Allos Therapeutics is looking for the next big breakthrough in the fight against cancer. Its lead candidate PDX (pralatrexate) is undergoing clinical trials for a relatively rare blood cancer ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.208 3/1/10 | — — |
—
—
|
| Last Quarter | -0.208 9/30/09 | -0.21 9/30/09 |
-0.002
Missed
|
| 2 Quarters Ago | -0.168 6/30/09 | -0.19 6/30/09 |
-0.022
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | -392,736.00 |
| Operating Income | -18.87 M | -53.64 M |
| Net Income | -18.67 M | -51.73 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts